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Resistance and tolerance are two alternative strategies hosts can adopt to
survive infections. Both strategies may be genetically controlled. To date,
the relative contribution of resistance and tolerance to infection outcome
is poorly understood. Here, we use a bioluminescent Listeria monocytogenes
(Lm) infection challenge model to study the genetic determination and
dynamic contributions of host resistance and tolerance to listeriosis in four
genetically diverse mouse strains. Using conventional statistical analyses,
we detect significant genetic variation in both resistance and tolerance, but
cannot capture the time-dependent relative importance of either host strat-
egy. We overcome these limitations through the development of novel
statistical tools to analyse individual infection trajectories portraying simul-
taneous changes in infection severity and health. Based on these tools, early
expression of resistance followed by expression of tolerance emerge as
important hallmarks for surviving Lm infections. Our trajectory analysis
further reveals that survivors and non-survivors follow distinct infection
paths (which are also genetically determined) and provides new survival
thresholds as objective endpoints in infection experiments. Future studies
may use trajectories as novel traits for mapping and identifying genes that
control infection dynamics and outcome. A MATLAB script for user-friendly
trajectory analysis is provided.1. Background
Two alternative host response strategies to pathogen challenge contribute to
survival: resistance, defined as the ability of a host to limit or inhibit pathogen
replication, thus reducing infection severity [1]; and tolerance, defined as the
ability of an infected host to limit the impact of infection on fitness or health.
Tolerance mechanisms reduce or prevent damage associated with pathogen
challenge, but have no direct impact on the pathogen itself [1–4]. In addition,
tolerance is an important mechanism for the coevolution of symbiotic inter-
actions between beneficial commensal microbes and the host, which has long
been recognized in both plants and animals [5,6]. As host strategies, both
resistance and tolerance may be genetically determined [2,7,8]. Assessment
of their relative contribution to survival requires quantitative estimates of
resistance and tolerance based on empirical evidence. Resistance may be
defined as the inverse of infection severity, conventionally quantified by
measures of within-host pathogen burden. Obtaining quantitative estimates
of tolerance has proved difficult in practice, owing to its statistical definition
as reaction norm of health with respect to changes in pathogen burden
[2,9,10] and the high frequency of measurements associated with constructing
and analysing reaction norms [10–13]. Although conceptually defined at the
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Figure 1. An infection severity–health (SH) trajectory for an individual
mouse. (a) Illustration of trajectory phases from start of infection to death.
A trajectory for an individual mouse was produced by plotting longitudinal
pairwise measurements of body weight (BW) and infection severity (bacterial
load measured by log-transformed light intensity plus one; LLI) in a two-
dimensional space, and following their progression over time. The graph
also shows the four characteristic phases of infection associated with distinct
changes in infection severity and health (indicated by arrows), as described in
the text. (b) Illustration of trajectory vectors and resulting sequences. The tra-
jectory vector V_0 with components VH (change in %BW) and VS (change in
infection severity) represents simultaneous change in infection severity
(decrease; S2) and health (increase; Hþ) between 0 and 1 dpi. The
bottom right panel shows the four quadrants (SþH2, S2H2, S2Hþ,
SþHþ) in the SH plane specifying the direction of a trajectory vector,
together with the associated sequence numbers (1–4). Each trajectory is
mapped to a sequence comprising 14 numbers, representing the directions
of the trajectory vectors at 14 consecutive daily intervals, and with the
sequence number 0 indicating death. The trajectory of the individual depicted
in this figure corresponds to the sequence f3,2,2,1,1,2,0,0,0,0,0,0,0,0g (i.e. it
died after dpi 6).
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only be obtained at the level of groups of (related) individ-
uals, which constitutes a major limitation to unravelling the
host genetic regulation of tolerance [10–12].
These static definitions of resistance and tolerance, and
the limitation of estimating tolerance at the group level,
cannot further our understanding of the relative contribution
of resistance and tolerance to individual survival, which is
likely to change over the time course of infection [14].
Recently, individual health trajectories have been introduced
as potentially powerful tools to capture the dynamic nature
of infection and its impact on health in individual hosts
[14,15]. Trajectories are constructed by plotting individual
measurements of infection severity (e.g. pathogen burden)
against health in two-dimensional space at different stages
of the infection. Following this pairwise progression over
time produces a trajectory that illustrates the dynamic inter-
play of resistance and tolerance mechanisms by describing
how changes in within-host pathogen burden are associated
with changes in health throughout the infection period, not
currently captured by static definitions of resistance and tol-
erance (figure 1a). We suggest that using trajectories as an
alternative to conventional statistical analysis of resistance
and tolerance will help describe individuals’ infection paths
towards a specific outcome (e.g. death or survival), and
reveal critical stages of the infection associated with the great-
est impact on health or fitness. It has been postulated that
infection trajectories can be classified into distinct trajectory
types [14,15] that may be linked to genetic background of
the host [14]. It may thus be possible to map host genotypes
to specific trajectory types, and target these for genetic
improvement of host response to infections [15].
Although proved to be powerful on conceptual grounds,
the use of trajectories to study host response to infection has
not previously been supported by experimental data [14,15].
Their wider application in infectious disease research has
been hampered by the lack of statistical methods for quanti-
tative trajectory analyses [12]. Trajectories often display loops
(figure 1a), which implies that they cannot be represented
by mathematical functions, and are thus not amenable to
conventional statistical models.
In this study, we develop a novel statistical framework
for quantitative trajectory analysis, making use of non-
invasive bioluminescent imaging tools to analyse the time
course of listerial infection in four inbred mouse strains.
Listeria monocytogenes (Lm) is a Gram-positive, facultative
intracellular bacterium that causes food-borne infections in
animals and humans. Lm is responsible for the life-threaten-
ing disease listeriosis in elderly and immunocompromised
individuals [16,17]. In healthy individuals, Lm infections are
usually self-limited but can cause acute, febrile gastroenteritis
[18]. Inbred mouse strains differ substantially in their appar-
ent susceptibility to listeriosis, through contributions of
multiple genetic loci [19–21], but genetic variation in toler-
ance to Lm, and the relative contributions of resistance and
tolerance to survival, are currently unknown. We use this
model system (i) to determine whether there is genetic vari-
ation in tolerance to Lm, and whether mouse strains rank
similarly in terms of resistance and tolerance, (ii) to study
the kinetic infection severity–health (SH) relationships
using trajectory analysis, and their association with survival,
and (iii) to assess whether different host genotypes map on to
distinct trajectory types.2. Material and methods
(a) Mice
The data were obtained from Lm infection challenge experiments
of 84 mice from four genetically diverse inbred mouse strains as
outlined by Bergmann et al. [22]. Briefly, female mice aged
between 9 and 10 weeks from the strains A/J, BALB/cJ (BALB)
and C57BL/6 J (B6 J), and C3HeB/FeJ (C3H) were orally infected
with bioluminescent Lm as described below. The inbred mouse
strains were selected because of known differences in resistance
to listeriosis development, similar mature body weights, and
for their suitability for in vivo bioluminescence imaging (BLI).
All mice were subjected to BLI or analysed for bacterial organ
loads. On 1, 3, 5 and 7 days post-infection (dpi), 3–8 mice per
strain were sacrificed to measure colony forming units (CFU)
of Lm from organ homogenates [22]. This enabled assessment
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the infection severity measures obtained by the BLI analysis
(see below). Ten mice per strain were maintained after inocu-
lation until 14 dpi, or until they had to be euthanized due to
reaching humane endpoints of infection severity. This was the
case for all mice from strain C3H, 80% of A/J mice and 40% of
BALB mice, which were all euthanized between 5 and 7 dpi
due to onset of clinical signs of advanced listeriosis, according
to established protocols and approved animal welfare regu-
lations [22]. All mice were housed under specific-pathogen-free
conditions. At the start of the experiment, all mice had reached
mature body weights. Thus, any changes in body weight (BW)
post-infection were assumed to be a direct consequence of the
infection challenge.
(b) Infection protocol
Prior to challenge with Lm, the mice were acclimatized for one to
two weeks in the facility. On the day prior to infection, the mice
were starved overnight, with drinking water replaced with car-
bonate buffered water. The next day, mice were intragastrically
challenged with 5  109 CFU Lm EGDe-InlA-mur-lux, an inter-
nalin A (inlA) modified strain of Lm as previously described
[22,23]. After infection challenge mice had ad libitum access to
both food and water.
(c) Measurement of infection severity and health
In line with the literature, resistance was quantified as an inverse
measure of infection severity [2], defined here in terms of log-
transformed measures of light intensity (LLI) obtained daily
from bioluminescent in vivo imaging (see electronic supplemen-
tary material, text S1). Higher LLI values correspond to higher
Lm loads, which is indicative of higher infection severity [19].
As Lm infection in adult mice causes a significant drop in
BW, BW was used as an indicator of impact of the infection on
health. BW was recorded for each individual mouse immediately
prior to infection, and daily post-infection over the 14-day dur-
ation of the experiment. The impact of infection on health at a
particular dpi was then represented as percentage of BW
(%BW) loss at that day from the initial BW at 0 dpi, and %BW
maintained at that day was considered as the daily indicator
for health.
(d) Conventional statistical analysis of resistance and
tolerance
The statistical analysis used data only from the 40 mice that had
not been analysed prior to 14 dpi for CFU counts, as only these
provided information about the association of resistance and tol-
erance to survival. Data were analysed with the SAS statistical
package (2010, v. 9.3) using procedure proc MIXED.
(i) Estimating resistance and tolerance based on peak infection
severity and minimum health
In accordance with Ra˚berg et al. [2], we defined resistance in
terms of maximum infection severity, here represented by peak
LLI levels over the two-week observation period. Tolerance esti-
mates were obtained accordingly based on maximum infection
severity (peak LLI) and minimum health (maximum %BW
loss) achieved during the observation period.
To assess genetic variation in resistance, a linear mixed model
was used with peak LLI as the dependent variable, and mouse
strain, binary survival outcome (succumbed to infection within
14 dpi, termed ‘non-surviving’; did not succumb to infection,
termed ‘surviving’), and their interactions as fixed effects.
In line with existing studies of tolerance genetics [2,13], an
analysis of covariance (ANCOVA) was used to assess geneticvariation in tolerance. The ANCOVA was performed using
maximum %BW loss as dependent variable and peak LLI as
independent variable, and mouse strain, survival outcome and
the corresponding interactions as fixed effects. The intercept was
fixed at zero, corresponding to zero %BW loss in the absence
of infection. The ANCOVA slope coefficients resulting from
regressing individual health measures against infection severity
provide group estimates of tolerance, where steeper negative
slopes correspond to less tolerant groups. Differences between
these slope estimates based on the F-test statistics for strain-by-
infection severity interaction thus provide evidence for genetic
variation in tolerance.
(ii) Assessing the sensitivity of resistance and tolerance estimates
to time of measurement
To determine the sensitivity of resistance and tolerance estimates to
the timing of measurement, we replaced the extreme measures of
peak LLI and maximum %BW loss with daily measures of LLI
and%BWloss to obtaindaily least squaremeans (LSM) for infection
severity (inverse of resistance) and tolerance slope for every mouse
strain bysurvival outcomeusing the repeatedmeasurementmodels
as outlined in the electronic supplementary material, text S2.
(e) Infection severity—health trajectories
Infection SH trajectories were generated by plotting the 14 daily
health measurements (represented by %BW maintained) against
the corresponding infection severity measures (LLI) recorded
until 14 dpi for each individual, or until time of death if infec-
tion-dependent euthanasia occurred prior to 14 dpi. Successive
scatter points were connected using the spline curve and, for
illustrative purposes, smoothed using the SM30 smoothing pro-
cedure in SAS. Figure 1a shows an example of a trajectory;
individual trajectories of all mice in consideration are presented
in the electronic supplementary material, text S3.
(i) Trajectory comparison and numerical representation
Trajectories were first visually inspected to determine common
features and differences related to levels and timing of simul-
taneous changes in infection severity and health. ‘Bad
neighbourhoods’, associated with subsequent death due to infec-
tion, were identified in the two-dimensional phase plane by
simply overlaying trajectories of surviving mice and those that
succumbed to infection.
For statistical comparison of trajectories associated with differ-
ent individuals, trajectories were mapped to numerical sequences,
which were constructed as follows: first, for each individual trajec-
tory, daily two-dimensional vectors V k ¼ (VðSkÞ, VðHkÞ) were
produced as shown in figure 1b, where VðSkÞ represents the
change in infection severity (in LLI units) from day k2 1 to day
k, and VðHkÞ represents the corresponding change in health
(%BW change). The magnitude of V_ k (i.e. Vk) given by
V k ¼
p
(VðSkÞ2 þ VðHkÞ2 )
describes the rate of change in the two-dimensional host state
between days k21 and k (figure 1b). The direction of V2k (deter-
mined by the signs of both vector components) indicates whether
an increase or decrease in infection severity (Sþ/S2) between
days k21 and k is associated with a simultaneous improvement
or deterioration in health (Hþ/H2). Four possible sign combi-
nations give rise to four SH categories (1¼ SþH2, 2 ¼ S2H2, 3 ¼
S2Hþ and 4 ¼ SþHþ) according to which quadrant in the SH
plane the trajectory vector faces (figure 1b). To reduce the impact
of measurement noise in the statistical analysis, Sþ or H2 were
only assigned if infection intensity had increased by more than
0.1 LLI units, and BW had dropped by more than 2% compared
with the last measurements, respectively. Otherwise, changes in
rspb.royalsocietypublishing.org
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stringing the 14 daily consecutive SH combinations together gener-
ated an SH time series for each individual represented by a
sequence of numbers between 0 and 4, where 0 indicates death of
the host and 1–4 refer to the different combinations of simul-
taneous changes in infection severity and health as specified
above (figure 1b).
(ii) Statistical analysis of trajectory sequences
Representing trajectories by numerical sequences allowed quan-
titative comparison of trajectories associated with different
individuals. For this purpose, Hamming distances between all
pairs of individual trajectory sequences, describing the pro-
portions of non-zero sequence elements that differed between
two sequences, were calculated. To prevent sequences associated
with individuals who succumbed to infection within the 14-day
observation period being assigned shorter distances, sequences
were truncated to the last time point where both individuals of
the pair in consideration were still alive.
In order to determine whether the 40 trajectories could be
classified into few distinct types depending on their patterns as
had been proposed previously [14,15], cluster analysis was car-
ried out using the ‘clusterdata’ function in MATLAB (v. R2013b),
with the truncated Hamming distances as measure of similarity,
and the weighted average distance as distance metric between
clusters. The number of maximum clusters specified was 2, 4
and 6. Resulting clusters were visualized using BIOLAYOUT
EXPRESS 3D [24].
Furthermore, a permutation test (in which trajectory sequences
were randomized) was applied to test statistically significant
differences between (truncated) trajectory sequences belonging to
different clusters, mouse strains or survival groups. The permu-
tation test assessed whether truncated Hamming distances
between any two groups were on average significantly larger
than the correspondingwithin-group distances. The corresponding
MATLAB script for generating sequences, calculating Hamming dis-
tances, and performing cluster analysis and permutation tests is
provided in the electronic supplementary material, text S5.3. Results
Infectionwas established in allmice, as indicated by high levels
of LLI, and all mice experienced a drop in BWat a certain stage
of infection, although at varying levels and duration. None of
the mice were able to clear the infection within the 14-day
experimental infection period. All B6J mice survived the infec-
tion period, whereas all C3H mice succumbed to infection
within 6 dpi. There was within-strain variation in survival out-
come forA/J and BALBmice: twoA/Jmice and six BALBmice
survived until the end of the experimental observation period.
This led to the following sixmouse strains by survival outcome
groups: C3H, B6J, A/J non-survivors, A/J survivors, BALB
non-survivors and BALB survivors.
(a) Estimates of resistance and tolerance
(i) Estimates of resistance and tolerance based on peak infection
severity and minimum health
Analysis of resistance revealed statistically significant strain
and survival effects, as well as strain-by-survival interactions
( p, 0.05; figure 2a). There was no statistically significant
difference in resistance among the non-survivors, but all
non-survivors (non-surviving BALB or A/J mice and C3H)
ranked significantly lower in terms of resistance than any sur-
vivor (figure 2a). The mouse strains also differed significantlyin tolerance to Lm infection, and tolerance varied between
survival groups within the mouse strains (figure 2b). How-
ever, the ranking of the strains differed for the two traits
(figure 2). In particular, non-survivors did not rank consist-
ently lower in tolerance than survivors. C3H and B6J
strains characterized by 0% and 100% survival, respectively,
were at opposite ends of the resistance spectrum, but had
similar tolerance estimates.
(ii) Dynamic trends in resistance and tolerance estimates
Although the actual resistance and tolerance estimates were
sensitive to the timing of measurements, genetic variation
in both resistance and tolerance could be detected throughout
the entire 14-day infection period (electronic supplementary
material, figure S2 and text S2). Ranking in both traits was
relatively time stable, except for a reverse in ranking of A/J
mice, which started the experiment as the most tolerant
strain, and emerged as the least tolerant out of the three
remaining mouse strains. B6J emerged as the most resistant
mouse strain as early as 2 dpi, and eventually was also the
most tolerant strain. In accordance with the results above,
non-survivors differed significantly from survivors in resist-
ance only, indicating that resistance may be more important
than tolerance for survival of Lm infection.
(b) Trajectory analysis
(i) Trajectory characteristics and determinants of survival
Visual inspection of individual trajectories (figure 3; electro-
nic supplementary material, text S3) revealed common
patterns in individuals’ routes of infection and distinct survi-
val characteristics. Four distinct phases over the course of
infection were identified with characteristic changes in infec-
tion severity and health, as represented by different infection
severity and health (SH) combinations (figure 3). Phase 1
described the establishment of infection during 0–1 dpi,
and is related to the initial reduction in infection severity
due to partial clearance of the inoculated pathogen
accompanied by partial recovery in BW (i.e. S2Hþ). This
phase was seen in all mice except C3H mice, most of which
experienced weight loss (i.e. S2H2). Phase 2 corresponded
to a period during which infection severity was stable but
BW continued to drop (S2H2). Phase 3 was associated with
resurgence in pathogen load and continued weight loss (i.e.
SþH2). The final phase 4 differed between survivors and
non-survivors. All survivors regained weight and controlled
infection severity. Non-survivors, by contrast, continued to
lose BW, although some were able to limit pathogen load.
Mice in this phase generally fluctuated between expression
of S2Hþand SþHþ. With the exception of phase 1, which
lasted one day for all mice, the duration of the individual
phases varied between mice. Only mice that survived the
infection experienced an improvement in health (Hþ) at
some stage after 4 dpi.
By overlaying trajectories, an infection severity threshold of
approximately 6.5 LLI units for pathogen resurgence could be
identified that discriminated between survival and death
(figure 4). All mice that had crossed this threshold after 1 dpi
succumbed to infection, regardless of their genotype, the
exact day when the threshold was crossed (which occurred
between 4 and 5 dpi) or whether infection severity temporarily
decreased thereafter. All mice that suppressed pathogen repli-
cation below this threshold survived. Interestingly, there was
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Figure 2. Least square mean (LSM) estimates for resistance and tolerance based on measures of maximum infection severity and minimum health. (a) LSM resist-
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of animal welfare regulations (figure 4). The results suggest
that trajectories can provide more predictive thresholds for
the definition of ethical experiment terminating endpoints
than arbitrary cut-off values for BW losses.
(ii) Statistical analysis and genetic footprint of infection
severity–health trajectories
Cluster analysis, combined with a permutation test, applied to
the corresponding (truncated) trajectory sequences indicated
that individual trajectories group into distinct trajectory types
(electronic supplementary material, text S4). When the stipu-
lated maximum number of clusters was two, the resultingclusters comprised either non-survivors or survivors. The per-
mutation test confirmed a highly significant difference in the
truncated SH sequences associated with both survival groups
( p, 0.0001). Hence, infection paths of mice that succumbed
to infection were significantly different to those of surviving
mice at the early stage of infection.
When the stipulated maximum number of clusters was
gradually increased, four distinct trajectory clusters (p, 0.02,
for all cluster pairs) emerged, with the greatest sequence differ-
ences found between clusters comprising exclusively C3H and
B6J mice, respectively (figure 5). The different clusters corre-
spond to different survival outcomes and SH patterns within
survivors/non-survivors, respectively, rather than to the four
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Figure 3. Representative trajectories for each mouse strain by survival outcome, together with the corresponding numerical sequence representing daily changes in
infection severity and health (SH). We refer to figure 1 and the main text for explanation of the latter. The numbers in the trajectories denote the day at which the
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tory cluster is dominated by a specific mouse strain, suggesting
that trajectories are partly genetically determined (figure 5).
The permutation test applied to different mouse strains con-
firmed a statistically significant difference (p, 0.05) between
trajectory sequences associated with different mouse strains,
except for A/J and BALB mice (table 1). Interestingly, the trajec-
tory sequences of surviving and non-surviving BALB or A/J
mice were statistically indistinguishable (p ¼ 0.53 and p ¼ 0.06,
respectively), implying that within a mouse strain trajectory
sequences alone are insufficient for predicting survival outcome.4. Discussion
Host genetic variation in both resistance and tolerance can
account for a substantial part of the observed variation in
host response to infection [2,7,10,25]. Many studies have pro-
vided conclusive evidence for genetic variation in host
resistance to Lm [2,26–29]. We have demonstrated that mice
from genetically distinct inbred strains, previously found to
differ significantly in resistance to the bacteria, also differ in tol-
erance. By convention, resistance and tolerance are considered
as static traits that constitute alternative host defence strategies
against invading pathogens [2,3]. The data show clearly that
expression of resistance (reduction in pathogen load) and
tolerance (damage prevention and repair) and their relativecontribution to survival vary over the time course of infection.
We therefore propose a paradigm shift in considering resistance
and tolerance as dynamic, rather than static traits. In practice,
this can only be achieved through time series measurements
in individual infected hosts, which in turn depend upon non-
invasive technologies, such as imaging. Recently, there have
been rapid advances in the development of such imaging tech-
nologies [30–32], and this has led to increasing demands for
advanced statistical tools to analyse infection dynamics, such
as the trajectory methods proposed here.
The novelty of this research lies in the development of
simple and versatile mathematical tools for capturing the
dynamic development of resistance and tolerance in each indi-
vidual, and their relative importance on the outcome of
infection. The conventional reaction-norm approach to toler-
ance has severe limitations that have hampered progress in
tolerance studies [11]. First, it usually restricts tolerance esti-
mates to group level, which is not helpful for improving
tolerance of individuals or identifying tolerance genes.
Second, the high data demand associated with estimating tol-
erance parameters from this approach limits reaction norms
to linear models, thus ignoring all biological understanding
of the highly nonlinear and time-dependent relationship
betweenpathogen burden and health [13]. By contrast, individ-
ual trajectories, which can be easily constructed if longitudinal
measurements are available, illustrate how changes in infection
severity are related to health change within each individual
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Figure 4. Spaghetti plots of individual trajectories of each mouse strain. The purple line shows the infection severity threshold that discriminates between survivors
and non-survivors, independent of mouse inbred strain. All non-survivors except for one A/J mouse had crossed this threshold after 1 dpi, whereas none of the
survivors had crossed this threshold after 1 dpi.
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and tolerance, the two-dimensional trajectory vectors crudely
reflect how resistance and tolerance are coexpressed at different
stages of infection. For example, simultaneous decrease in infec-
tion severity and health (S2H2) reflects expression of resistance
at the cost of deterioration in health, indicating incomplete toler-
ance. As demonstrated in this study, trajectories can reveal
distinct phases of infection associated with different patterns
of coexpression of resistance and tolerance, and illustrate for
each individual the two-dimensional path towards death or sur-
vival. Previous studies of trajectories have defined ‘bad
neighbourhoods’ in the infection-severity health plane that
appear predictive for fatal infection outcome [2,12,15]. In the
mouse data, we identified an infection severity threshold that
discriminated between death and survival (figure 4). All mice
that succumbed to the infection experienced a drastic increase
in infection severity between 3 and 7 dpi, whereas all survivors
managed to restrict pathogen resurgence below this threshold
during this critical phase. The critical infection severity
threshold was independent of host genotypes and timing. Any
mouse that crossed this threshold eventually succumbed to
infection, even if thereafter it managed to reduce infection sever-
ity below the threshold. Interestingly, there was no apparent
health threshold that discriminated between death and survival.
All mice experienced BW loss as a consequence of infection, but
all the survivors and none of the non-survivors managed to
recover some of the lost weight, in some cases despite continued
increase in pathogen load. Our results thus indicate that both
early expression of resistance and tolerance at the later stages
of infection are important determinants of survival to Lm infec-
tions. Discriminatory thresholds, such as those identified here,
can provide more informative criteria than BW for defining
humane endpoints for termination of animal infection.
Individual trajectories have been used previously to classify
andpredict host responses to infection, but their assessmentwaslimited to qualitative analysis [14,15]. By transforming visual
trajectories into numerical sequences that preserve the key topo-
logical trajectory features, wewere able to subject trajectories to
rigorous statistical analysis. Our statistical analysis confirmed
that individual trajectories cluster into a limited number of
genetically regulated distinct trajectory types [14,15]. Trajec-
tories thus open new avenues for genetic studies of host
response to infections. Future studies may focus on genetic dis-
section of different trajectory types to identify novel genetic
variants that control infection dynamics at a molecular level.
Despite a clear genetic footprint in trajectory patterns,
trajectory sequences could not capturewithin-strain differences
in survival outcome. This could be due to several reasons: first,
BWmayonly be a crude indicator of health [2]. Alternatively, as
mice were euthanized due to welfare considerations based
upon weight loss, some of the mice classified as non-survivors
may actually have survived the infection. Furthermore, survi-
val outcome may be partly determined by individual
differences in the gastro-intestinal flora, which have been
found to show substantial inter-strain variation even in simi-
larly highly controlled environments as used in our study
[33]. Higher-dimensional trajectories comprising other types
ofmeasurements (e.g. related to the immune response ormicro-
biota) in addition tomeasures of health and pathogen loadmay
shed light on relevant host responsemechanisms controlling an
individual’s infection path and its outcome.Note that, although
more difficult to visualize, multi-dimensional trajectories
can still be represented as a series of vectors defined by their
direction and length, and are thus amenable to similar statistical
analyses as those presented here.
Previous studies have estimated an antagonistic relation-
ship between resistance and tolerance at the phenotypic
and genetic level [7,34]. These results led to the notion of a
trade-off between resistance and tolerance mechanisms, and
their consideration as alternative host defence strategies to
Figure 5. Graphical representation of similarities between truncated trajectory sequences associated with different mouse inbred strains and survival groups within
the mouse strains. Each node (ball) represents an individual mouse, and each edge (connecting line) represents the degree of similarity between trajectory
sequences of two mice, represented by 12H, where H is the pairwise Hamming distance. Only similarities 12H . 0.8 are depicted in the graph. Colours represent
different mouse strains and survival groups, respectively. The graph was produced with BIOLAYOUT EXPRESS 3D software [24], which spatially distributes the nodes
according to the similarity measure 12H, so that individuals with similar trajectory sequences (i.e. 12H close to 1) are placed in close proximity to each
other, whereas individuals with different trajectory sequences (i.e. 12H close to 0) are placed far apart. The graph illustrates that differences between trajectory
sequences were on average smallest within each mouse strain, and greatest between C3H mice (light blue; all succumbing to infection) and B6J mice (red; all
surviving infection). Within the A/J (black) and BALB (green) mice, sequences associated with survivors and non-survivors survival (survivors: light; non-survivors:
dark) did not fall into different visual clusters. The graphical results were confirmed by statistical cluster analysis (see text).
Table 1. p-values of permutation test used to assess whether mouse
strains differ significantly in their SH trajectory sequences.
between-
strain A/J C3H B6J BALB
A/J ,1026 0.0003 0.31
C3H ,1026 0.0002
B6J 0.0002
BALB .
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quences for both hosts and pathogens [35–38]. These studies
do not take account of the dynamic relationships that emerge
from our study. For example, expression of resistance at the
early stages of infection is likely to affect the expression of
tolerance at the later stages as fast pathogen clearance may pre-
vent tissue damage and obviate any requirement for damage
prevention or repair mechanisms associated with tolerance.
Conventional statistical models that do not account for this
kind of interdependence between traits may produce a
spurious antagonistic relationship between traits, on both the
phenotypic and genetic levels [39], even if resistance and toler-
ance are controlled by different sets of genes or genetic
pathways as suggested by immunological evidence [1,4]. Tra-
jectories enable us to bypass the complex relationship
between resistance and tolerance, and may give rise to novel
phenotypes for future genetic analyses that may lead to the
discovery of genes that control an individual’s infection path.All of the infected mice experienced a substantial BW loss
after the initial reduction in pathogen burden, but of itself, BW
loss did not influence survival. From a resource allocation per-
spective, this would suggest that resistance mechanisms are
costly [40,41]. By reducing resources allocated to other functions,
such as searching for and digesting food, the host may be able to
direct resources to the immune response, resulting in temporary
BW loss. This has been put forward as the evolutionary basis
of pathogen-induced anorexia and ‘sickness’ behaviours
[40,42–44]. Our previous applications of the resource allocation
theory to assess the effect of genetic resistance on the long-term
effects of infection, showed that hosts with greater genetic resist-
ancemaysuffergreaterperformance loss (e.g.growthorBWloss)
in the short term, but are able to revert to original levels of per-
formance faster than non-resistant genotypes [45]. This is
consistent with our study, where the B6J mice emerged as most
resistant genotype after 3 dpi and were the only mouse strain
that managed to fully restore the original BWwithin 14 dpi.
To study the dynamic coexpression patterns of resistance
and tolerance to Lm in different mouse inbred strains, we
have taken advantage of a bioluminescent Lm infection
model in which the listerial strain EGDe-InlA-mur-lux recog-
nizes the host receptor E-cadherin and intestinal expressed
N-cadherin [22,23,46,47]. Other Lm infection models have
been shown to elicit different host responses [47,48]. It
would be interesting to apply our novel methods to data
from these models to determine whether the dynamic contri-
butions of resistance and tolerance to survival are preserved
across different pathogen and host strains. However, this
would require the introgression of humanized alleles of
rspb.royalsocietypublishing.org
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backgrounds followed by repeated backcrossing to make
mice permissive to oral Lm challenge [22,26].
In conclusion, our study complements existing evidence for
genetic variation in both host resistance and tolerance, and
for the importance of both host strategies in fighting infections
[1–9,21,45]. However, our study also highlights the potential
benefits that may arise from considering the dynamic patterns
of coexpression of genetic resistance and tolerance over the
time course of infection. Trajectories capture the dynamic
signature and genetic footprint of both mechanisms on the
level of individuals, together with their impact on survival.
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